119 related articles for article (PubMed ID: 8268386)
1. Chitosan matrix for oral sustained delivery of ampicillin.
Chandy T; Sharma CP
Biomaterials; 1993 Oct; 14(12):939-44. PubMed ID: 8268386
[TBL] [Abstract][Full Text] [Related]
2. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies.
Chandy T; Sharma CP
Biomaterials; 1992; 13(13):949-52. PubMed ID: 1477265
[TBL] [Abstract][Full Text] [Related]
3. Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads.
Chandy T; Sharma CP
Biomaterials; 1996 Jan; 17(1):61-6. PubMed ID: 8962949
[TBL] [Abstract][Full Text] [Related]
4. Drug release behavior of beads and microgranules of chitosan.
Gupta KC; Ravi Kumar MN
Biomaterials; 2000 Jun; 21(11):1115-9. PubMed ID: 10817263
[TBL] [Abstract][Full Text] [Related]
5. Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis.
Vasudev SC; Chandy T; Sharma CP
Biomaterials; 1997 Mar; 18(5):375-81. PubMed ID: 9061177
[TBL] [Abstract][Full Text] [Related]
6. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
Chandy T; Rao GH; Wilson RF; Das GS
Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres.
Giunchedi P; Genta I; Conti B; Muzzarelli RA; Conte U
Biomaterials; 1998; 19(1-3):157-61. PubMed ID: 9678863
[TBL] [Abstract][Full Text] [Related]
8. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin.
Hari PR; Chandy T; Sharma CP
J Microencapsul; 1996; 13(3):319-29. PubMed ID: 8860687
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads.
Aiedeh K; Taha MO
Eur J Pharm Sci; 2001 May; 13(2):159-68. PubMed ID: 11297900
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres.
Lee BJ; Choe JS; Kim CK
J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955
[TBL] [Abstract][Full Text] [Related]
11. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
Anal AK; Stevens WF; Remuñán-López C
Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
[TBL] [Abstract][Full Text] [Related]
12. Release characteristics of chitosan treated alginate beads: II. Sustained release of a low molecular drug from chitosan treated alginate beads.
Sezer AD; Akbuğa J
J Microencapsul; 1999; 16(6):687-96. PubMed ID: 10575621
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery.
Shu XZ; Zhu KJ
Int J Pharm; 2000 May; 201(1):51-8. PubMed ID: 10867264
[TBL] [Abstract][Full Text] [Related]
14. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
Ganza-González A; Anguiano-Igea S; Otero-Espinar FJ; Blanco Méndez J
Eur J Pharm Biopharm; 1999 Sep; 48(2):149-55. PubMed ID: 10469933
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable chitosan matrix for the controlled release of steroids.
Chandy T; Sharma CP
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):745-60. PubMed ID: 1810408
[TBL] [Abstract][Full Text] [Related]
16. Buoyant sustained release granules based on chitosan.
Inouye K; Machida Y; Sannan T; Nagai T
Drug Des Deliv; 1989 Jan; 4(1):55-67. PubMed ID: 2775446
[TBL] [Abstract][Full Text] [Related]
17. Physical characteristics and release behavior of salbutamol sulfate beads prepared with different ionic polysaccharides.
el Fattah EA; Grant DJ; Gabr KE; Meshali MM
Drug Dev Ind Pharm; 1998 Jun; 24(6):541-7. PubMed ID: 9876620
[TBL] [Abstract][Full Text] [Related]
18. The controlled release of a drug from biodegradable chitosan gel beads.
Kofuji K; Ito T; Murata Y; Kawashima S
Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):579-81. PubMed ID: 10783085
[TBL] [Abstract][Full Text] [Related]
19. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties.
Foda NH; El-laithy HM; Tadros MI
Drug Dev Ind Pharm; 2004 Apr; 30(4):369-79. PubMed ID: 15132179
[TBL] [Abstract][Full Text] [Related]
20. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery.
Senel S; Ikinci G; Kaş S; Yousefi-Rad A; Sargon MF; Hincal AA
Int J Pharm; 2000 Jan; 193(2):197-203. PubMed ID: 10606782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
